Skip to content

Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth

Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth: Retrospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02447757
Enrollment
66
Registered
2015-05-19
Start date
2010-01-31
Completion date
2016-02-29
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Labor and/or Delivery

Keywords

Remifentanil, delivery, childbirth, analgesia, parturition, confinement

Brief summary

Retrospective observational study to determine the efficacy of remifentanil during the delivery. Authors will search the data in period between 2010 and 2014 in cohort of 100 parturients and obtain data of analgesic efficacy (VAS score after remifentanil analgesia induction) and parturients satisfaction with the method.

Detailed description

In retrospective observational study will authors search the documentation of parturients. The cohort size is estimated to 100 subjects, in period between 2010-2014. Excluded will be all patients who did not signed the informed consent for processing with their medical data.The main aim is to evaluate the efficacy of the remifentanil analgesia in parturients in the first phase of delivery. The analgesic efficacy will be evaluated by the change in VAS (visual analogue scale) score after induction of remifentanil analgesia Satisfaction will be evaluated by the questionary.

Interventions

DRUGremifentanil

Remifentanil analgesia during delivery

Sponsors

Hospital Sokolov
CollaboratorUNKNOWN
Brno University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* parturients during the delivery * administered remifentanil analgesia * signed informed consent

Exclusion criteria

* informed consent not signed * missing data about the analgetic method a analgetic efficacy

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of remifentanyl analgesia during the deliveryVAS score before the induction of remifentanyl infusion and 1hour after initiation of remifentanil analgesia during the first phase of deliveryTo evaluate the efficacy of remifentanil analgesia during the first phase of delivery in parturients by observing changes in VAS score

Secondary

MeasureTime frameDescription
Patient satisfaction with analgetic methodBefore initiation of anagetic method (first phase of delivery) and 1hour after childbirthPatients will fill the questionaire to obtain their opinion on the remifentanil analgesia

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026